Demonstrating Substantial Evidence of Effectiveness With One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 19, 2023
November 30, 2023
b9da6d6b-ce16-4b00-8230-317aa96fa4e7
Related Documents
Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices: Draft Guidance for Industry
Guidance DocumentSeptember 29, 2021Center for Drug Evaluation and Research
Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
Guidance DocumentJanuary 30, 2024Center for Drug Evaluation and Research
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products: Draft Guidance for Industry
Guidance DocumentDecember 20, 2019Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox